F
The startup manufactures and distributes a lipid-formulated ibuprofen that provides the analgesic effects equivalent to a double dose of standard liquid ibuprofen capsules. This formulation is specifically designed for patients experiencing acute joint or muscular pain, offering a more effective pain relief option.
Updated 18 months ago
Funding
$13.8M raised to dateRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
IAICFunding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- The startup manufactures and distributes a lipid-formulated ibuprofen that provides the analgesic effects equivalent to a double dose of standard liquid ibuprofen capsules. This formulation is specifically designed for patients experiencing acute joint or muscular pain, offering a more effective pain relief option.